Circulating Tumor Cells Market Analysis By Size, Share, Key Players, Trends, Insights, Dynamics, Future Outlook, Applications and Segmentation, Forecast to 2023
According to the report, the Global Circulating Tumor Cells Market was valued at USD 9.39 billion in 2017 and is expected to rise to a valuation of USD 28.3 billion by the end of 2023.
Market Research Future (MRFR) has announced a new release on the global circulating tumor cell market.
The report presents a detailed analysis of the market’s likely growth trajectory and drivers over the forecast period from 2018 to 2023, based on a solid examination of the CTC market’s growth over the past few years.
The clinical significance of circulating tumor cells was first recognized in 1869, but serious medical research within the context of the modern structure of the healthcare sector began in the 1990s.
These studies were inspired by calculations that showed that even small cancerous growths shedding cells at a small rate of less than 1% per day would produce enough circulating tumor cells in the bloodstream to be detectable.